VIVUS, Inc. (NASDAQ:VVUS) major shareholder North Tide Capital, Llc sold 28,027 shares of the firm’s stock in a transaction dated Monday, February 6th. The stock was sold at an average price of $1.10, for a total …
Sells
To say the past couple of months have been uncharacteristically bullish for Vivus, Inc. (VVUS) would be a significant understatement. After spending the past two years losing more than 90% of its value, Vivus stock
Vivus, Inc.
At Bidness, we are developing the most comprehensive and easy to use institutional financial data platform for investment management and investment banking. Our mission is to be the world’s most trusted financial data …
Large percentage drops always require that the stock post even larger percentage gains from the low in order to recover the old price point, and for VVUS that means the stock would have to gain 152.39% to get back to the …
VIVUS Inc. VVUS was a big mover last session, as its shares rose a little more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the …
NASDAQ3mon
Stock
On Jan 3, we issued an updated report on VIVUS, Inc. (VVUS - Free Report) . VIVUS’ three-month share price movement shows that the stock has significantly outperformed the Zacks classified Medical-Biomed/Genetics …
ZACKS1mon
In that article we said the following regarding VVUS stock: VVUS is currently range-bound between the 50-day and 200-day exponential moving averages. If a run-up in VVUS is to occur ahead of the EU approval decision, …
VIVUS, Inc. (NASDAQ:VVUS) major shareholder North Tide Capital, Llc sold 78,633 shares of VIVUS stock in a transaction on Friday, February 3rd. The shares were sold at an average price of $1.12, for a total value of …
Sells